Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 12;1(7):326-330.
doi: 10.1021/ml1000933.

A Direct Comparison of the Anticancer Activities of Digitoxin MeON-Neoglycosides and O-Glycosides: Oligosaccharide Chain Length-Dependent Induction of Caspase-9-Mediated Apoptosis

Affiliations

A Direct Comparison of the Anticancer Activities of Digitoxin MeON-Neoglycosides and O-Glycosides: Oligosaccharide Chain Length-Dependent Induction of Caspase-9-Mediated Apoptosis

Anand Krishnan V Iyer et al. ACS Med Chem Lett. .

Abstract

Digitoxin is a cardiac glycoside currently being investigated for potential use in oncology. While a number of structure-activity relationship studies have been conducted, an investigation of anticancer activity as a function of oligosaccharide chain length has not yet been performed. We generated mono-, di-, and tri-O-digitoxoside derivatives of digitoxin and compared their activity to the corresponding MeON-neoglycosides. Both classes of cardenolide derivatives display comparable oligosaccharide chain length-dependent cytotoxicity toward human cancer cell lines. Further investigation revealed that both classes of compounds induce caspase-9-mediated apoptosis in non-small cell lung cancer cells (NCI-H460). Since O-glycosides and MeON-neoglycosides share a similar mode of action, the convenience of MeON-neoglycosylation could be exploited in future SAR work to rapidly survey large numbers of carbohydrates to prioritize selected O-glycoside candidates for traditional synthesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Digitoxin mono-, di-, and tri-O-digitoxosides 13 and mono-, di-, and tri-MeON-digitoxosides 46.
Scheme 1
Scheme 1. Synthesis of Digitoxin Mono-, Di-, and Tri-O-digitoxosides 13
NBSH, o-nitrobenzenesulfonylhydrazide; DEAD, diethyl azodicarboxylate; and NMO, N-methylmorpholine-N-oxide.
Scheme 2
Scheme 2. Synthesis of Digitoxin Mono-, Di-, and Tri-MeON-digitoxosides 13
Figure 2
Figure 2
Summary of GI50 data from growth inhibition assays. Reciprocal GI50 values are displayed for clarity.
Figure 3
Figure 3
Summary of IC50 data from cytotoxicity assays. Reciprocal IC50 values are displayed for clarity; standard errors are depicted with error bars.
Figure 4
Figure 4
O-Digitoxosides 13 and MeON-digitoxosides 46 induce apoptosis in NCI-H460 non-small cell lung cancer cells. Apoptotic cells were quantified by Hoechst dye staining and microscopy. ZV = pan-caspase inhibitor ZVAD-FMK.
Figure 5
Figure 5
O-Digitoxoside 1 and MeON-digitoxoside 4 activate caspase-9, not caspase-8, in NCI-H460 non-small cell lung cancer cells. Cell lysates were incubated in fluorometric substrates for either caspase-8 (IETD-AFC) or caspase-9 (LEHD-AFC); samples were then read using a fluorescence plate reader. Ntx = no treatment. ZV = pan-caspase inhibitor ZVAD-FMK.

Similar articles

Cited by

References

    1. Kaplan J. H. Biochemistry of Na,K-ATPase. Annu. Rev. Biochem. 2002, 71, 511–535. - PubMed
    1. Haux J. Digitalis; impinges on more than just the (ion-) pump. Med. Hypotheses 2002, 59, 781–782. - PubMed
    1. Stenkvist B. Cardenolides and cancer. Anti-Cancer Drugs 2001, 12, 635–636. - PubMed
    1. Newman R. A.; Yang P.; Pawlus A. D.; Block K. I. Cardiac Glycosides as Novel Cancer Therapeutic Agents. Mol. Interventions 2008, 8, 36–49. - PubMed
    1. Lopez-Lazaro M.; Pastor N.; Azrak S. S.; Ayuso M. J.; Austin C. A.; Cortes F. Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients. J. Nat. Prod. 2005, 68, 1642–1645, and references cited therein. - PubMed